This technical report provides a summary of the evidence available at the time of the publication and what will be required in the future to

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9-15 May 2021 and includes updates on COVID-19, dengue and influenza.

The aim of this Threat Assessment Brief is to assess potential public health implications of B.1.617 variants for EU/EEA countries, with a focus on lineage

The downloadable data files contain information on COVID-19 vaccination in the EU/EEA. The data are presented in the Vaccine Tracker and collected through The European

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 May 2021 and includes updates on COVID-19, Ebola virus disease, MERS-CoV,

The main aim of this activity is to collect information on the severity of breakthrough COVID-19 infections in outbreaks, by SARS-CoV-2 variant and vaccine product.

This document outlines the public health considerations for the use of rapid antigen detection tests (RADTs), including self-test RADTs to detect SARS-CoV-2 in individuals in

ECDC has joined forces with EU-OSHA, the EU agency for occupational safety and health, to explore the use of rapid antigen tests for SARS-CoV-2, the

Joint ECDC – EU-OSHA infographic on the use of rapid antigen tests for SARS-CoV-2, the virus that causes COVID-19, in the workplace.

This document offers practical guidance for EU/EEA Member States on implementing genomic SARS-CoV-2 surveillance. It also includes advice on how to estimate the number of

This document outlines the use of saliva as a diagnostic sample for detecting SARS-CoV-2 infection, considering the advantages, limitations and uncertainties associated with the use

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 25 April – 1 May 2021 and includes updates on Crimean-Congo haemorrhagic